Actively Recruiting
Mechanisms of Fatigability With Diabetes
Led by University of Michigan · Updated on 2025-10-08
80
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
U
University of Michigan
Lead Sponsor
U
University of Illinois at Chicago
Collaborating Sponsor
AI-Summary
What this Trial Is About
Pre-diabetes (Pre-D) is a precursor to type 2 diabetes (T2D) and characterized by increased exercise fatigability of lower limb muscles, that can impede exercise performance. The cause for the increased fatigability in people with Pre-D is not known. Given the profound vascular disease present in people who have had uncontrolled diabetes for several years, we will determine whether dynamic, fatiguing contractions of the lower limb muscles in people with Pre-D are limited by vascular dysfunction at multiple levels along the vascular tree including the artery, arteriole, and/or capillary. This clinical trial involves a novel exercise training regime involving blood flow restriction to the exercising limb will be used as a probe to further understand the vascular mechanisms for increased fatigability in people with Pre-D and T2D. The long-term goal is to better understand what limits exercise and functional performance in people with diabetes to help develop targeted, more effective exercise programs.
CONDITIONS
Official Title
Mechanisms of Fatigability With Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 30 to 85 years
- Diagnosed with pre-diabetes (HbA1c 5.7-6.4% and fasting glucose 100-125 mg/dL)
- Controls with normal blood sugar levels (HbA1c 645.6% and fasting glucose 6499 mg/dL)
- Diagnosed with type 2 diabetes mellitus (HbA1c >6.5% and <10%)
You will not qualify if you...
- Signs or symptoms of neuropathy
- Use of medications associated with advanced stages of type 2 diabetes, including insulin
- Poor blood sugar control (HbA1c >10%)
- Peripheral edema
- Severe obesity (BMI >45 kg/m2)
- Untreated hypothyroidism
- Current smoking
- Hypertension
- Cardiovascular or musculoskeletal disease preventing exercise testing
- Use of hormone replacement drugs or vasoactive medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Michigan
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
Research Team
S
Sandra Hunter, PhD
CONTACT
S
Sarah Lessila, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here